Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22,998Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Braftovi

02 1Braftovi/Mektovi

PharmaCompass

01

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

Brand Name : Braftovi

arrow
USCC
Not Confirmed

Encorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 48

2018 Revenue in Millions : 0

Growth (%) : New launch

blank

02

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

03

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

04

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

05

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

06

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

07

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

08

Brand Name : Braftovi

Encorafenib

arrow
USCC
Not Confirmed

09

Brand Name : Braftovi/Mektovi

Encorafenib/Binimetinib

arrow
USCC
Not Confirmed